Justin Boysen Selected Research

choline salicylate

1/2021

Salicylates enhance CRM1 inhibitor antitumor activity by induction of S-phase arrest and impairment of DNA-damage repair.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Justin Boysen Research Topics

Disease

2	Neoplasms (Cancer) 01/2021 - 09/2018
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 08/2017 - 02/2011
1	Multiple Myeloma 01/2021
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Cytopenia 11/2018
1	Prostatic Neoplasms (Prostate Cancer) 09/2018

Drug/Important Bio-Agent (IBA)

1	choline salicylateIBA 01/2021
1	selinexorIBA 01/2021
1	SalicylatesIBA 01/2021
1	ibrutinibIBA 11/2018
1	Biomarkers (Surrogate Marker)IBA 09/2018
1	AndrogensIBA 09/2018
1	MK 2206IBA 08/2017
1	Bendamustine Hydrochloride FDA Link 08/2017
1	Rituximab (Mabthera)FDA Link 08/2017
1	Phosphotransferases (Kinase)IBA 02/2011
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2011

Therapy/Procedure

3	Therapeutics 01/2021 - 02/2011